홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 3-Amino-6-(3-{[(biphenyl-2-ylmethyl)amino]carbonyl}phenyl)-N-[(3S)-piperidin-3-yl]pyrazine-2-carboxamide

HRID 646767
인쇄

반응식

HRID 646767 반응식
[NH2:1][C:2]1[C:3]([C:9]([OH:11])=O)=[N:4][C:5](Br)=[CH:6][N:7]=1.CN(C(ON1N=[N:27][C:22]2[CH:23]=[CH:24][CH:25]=[N:26][C:21]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.N[C@H]1CCCN(C(OC(C)(C)C)=O)C1.C(N(CC)CC)C.[C:66]([C:69]1[CH:70]=[C:71](B(O)O)[CH:72]=[CH:73][CH:74]=1)([OH:68])=O.[C:78]1([C:84]2[CH:91]=[CH:90][CH:89]=[CH:88][C:85]=2[CH2:86][NH2:87])[CH:83]=[CH:82][CH:81]=[CH:80][CH:79]=1.Cl>CN(C=O)C.O.COCCOC.CO.O1CCOCC1.C(#N)C.O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[NH2:1][C:2]1[C:3]([C:9]([NH:27][C@H:22]2[CH2:23][CH2:24][CH2:25][NH:26][CH2:21]2)=[O:11])=[N:4][C:5]([C:73]2[CH:72]=[CH:71][CH:70]=[C:69]([C:66]([NH:87][CH2:86][C:85]3[CH:88]=[CH:89][CH:90]=[CH:91][C:84]=3[C:78]3[CH:83]=[CH:82][CH:81]=[CH:80][CH:79]=3)=[O:68])[CH:74]=2)=[CH:6][N:7]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

16

반응물 8

HCID 313Hydrochloric AcidHCID 8471TriethylamineHCID 81531Diisopropylethylamine2회HCID 2633661-Biphenyl-2-ylmethanamineHCID 1501975tert-butyl (3S)-3-aminopiperidine-1-carboxylateHCID 27339573-Carboxyphenylboronic acid
HCID 9886157
Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)
2회
HCID 185216003-Amino-6-bromopyrazine-2-carboxylic acid

생성물 1

HCID 686504283-Amino-6-(3-{[(biphenyl-2-ylmethyl)amino]carbonyl}phenyl)-N-[(3S)-piperidin-3-yl]pyrazine-2-carboxamide

시약·촉매·용매 7

HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)촉매HCID 887Methanol용매HCID 962Water용매2회HCID 6228Dimethylformamide용매2회HCID 80711,2-Dimethoxyethane용매HCID 312751,4-Dioxane용매HCID 18373917Acetonitrile--water (1/1)용매

실험 절차

To a solution of 3-amino-6-bromopyrazine-2-carboxylic acid (4.0 g, 18 mmol) in DMF, HATU (10.4 g, 27.5 mmol), N,N-diisopropylethylamine (8.5 mL, 27.5 mmol) and (S)-3-amino-1-N-Boc-piperidine (4.0 g, 20 mmol, commercially available from Astatech and Arch Corporation) were added. The reaction was allowed to stir at room temperature for 1 h. The reaction mixture was diluted with water (100 mL), extracted with ethyl acetate (3×, 200 mL), washed with 5% LiCl (3×, 100 mL) and brine (3×, 100 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford a brown solid (MS (ESI-LCMS) for C15H22BrN5O3: 400 (MH+). This material was taken up in ethylene glycol dimethyl ether (150 mL), and triethylamine (4.6 mL, 45 mmol), Pd(dppf)2Cl2 (2.3 g, 2.75 mmol), 3-carboxyphenylboronic acid (3.6 g, 21.8 mmol) and water (15 mL) were added. The reaction was refluxed at 85° C. and monitored by LCMS. The reaction was complete after 3 h. The solvent was removed under reduced pressure to afford a brown solid. The crude product was purified by silica gel chromatography to afford a yellow solid (MS (ESI-LCMS) for C22H27N5O5: 442 (MH+). A portion of this intermediate (50 mg, 0.11 mmol) was dissolved in DMF (1 mL), and HATU (62.7 mg, 0.165 mmol), N,N-diisopropylethylamine (29 μL, 0.16 mmol) and 2-phenylbenzylamine (24.2 mg, 0.132 mmol) were added. The reaction was stirred at room temperature and monitored by LCMS. The reaction was complete after 1 h. The crude product was purified by preparative HPLC and lyophilized to afford a white solid (MS (ESI-LCMS) for C35H38N6O4: 607 (MH+). This material was dissolved in methanol (2 mL), and 4M HCl in dioxane (2 mL) was added. The reaction was stirred at room temperature and monitored by LCMS. The reaction was complete after 1 h. The solvents were removed under reduced pressure to afford a yellow gel product. The yellow gel product was dissolved in acetonitrile-water (2 mL), frozen and lyophilized to afford a yellow solid: 1H NMR (400 MHz, d6-DMSO): δ 9.25 (t, 1H), 9.05 (d, 1H), 8.95 (s, 1H), 8.9 (d, 1H), 8.85 (d, 1H), 8.6 (s, 1H), 8.35 (d, 1H), 7.9 (d, 1H), 7.6 (t, 1H), 7.5-7.3 (m, 8H), 7.25 (m, 1H), 4.5 (d, 2H), 4.35 (m, 1H), 3.25 (m, 2H), 3.05 (m, 1H), 2.75 (m, 1H), 1.95-1.7 (m, 4H). MS (EI) for C30H30N6O2: 507 (MH+).

후처리

  1. extractionextracted with ethyl acetate (3×, 200 mL)
  2. washwashed with 5% LiCl (3×, 100 mL) and brine (3×, 100 mL)
  3. dry with materialdried over anhydrous sodium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customto afford a brown solid (MS (ESI-LCMS) for C15H22BrN5O3
  7. temperatureThe reaction was refluxed at 85° C.
  8. waitThe reaction was complete after 3 h
  9. customThe solvent was removed under reduced pressure
  10. customto afford a brown solid
  11. customThe crude product was purified by silica gel chromatography
  12. customto afford a yellow solid (MS (ESI-LCMS) for C22H27N5O5
  13. stirringThe reaction was stirred at room temperature
  14. waitThe reaction was complete after 1 h
  15. customThe crude product was purified by preparative HPLC
  16. customto afford a white solid (MS (ESI-LCMS) for C35H38N6O4
  17. stirringThe reaction was stirred at room temperature
  18. waitThe reaction was complete after 1 h
  19. customThe solvents were removed under reduced pressure
  20. customto afford a yellow gel product
  21. temperaturefrozen
  22. customto afford a yellow solid

출처 및 근거

ORD 기록
ord-cab60588182040a3bbff54ec18927e16
출처 데이터셋
uspto-grants-2010_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07704995B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트